{"id":3804,"date":"2019-04-27T13:00:05","date_gmt":"2019-04-27T11:00:05","guid":{"rendered":"https:\/\/aa-pnh.pe-dev.de\/positive-opinion-for-ravulizumab\/"},"modified":"2021-12-27T10:08:03","modified_gmt":"2021-12-27T09:08:03","slug":"positive-opinion-for-ravulizumab","status":"publish","type":"post","link":"https:\/\/aa-pnh.org\/en\/positive-opinion-for-ravulizumab\/","title":{"rendered":"positive opinion for ravulizumab"},"content":{"rendered":"<p>Ravulizumab (Ultomiris&reg;), the successor to eculizumab (Soliris&reg;) by the manufacturer Alexion Pharmaceuticals, Inc., has been approved by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency<!--more-->. The CHMP issued a positive opinion for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) with Ultomiris&reg; (ravulizumab).<\/p>\n<p>Please note that this positive opinion from the CHMP does not yet mean that a marketing authorization has been granted, which requires a decision by the European Commission. The European Commission will review the CHMP recommendation and usually take its final decision within two months. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ravulizumab (Ultomiris&reg;), the successor to eculizumab (Soliris&reg;) by the manufacturer Alexion Pharmaceuticals, Inc., has been approved by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"gallery","meta":{"footnotes":""},"categories":[80],"tags":[],"class_list":["post-3804","post","type-post","status-publish","format-gallery","hentry","category-studies","post_format-post-format-gallery"],"_links":{"self":[{"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/posts\/3804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/comments?post=3804"}],"version-history":[{"count":0,"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/posts\/3804\/revisions"}],"wp:attachment":[{"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/media?parent=3804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/categories?post=3804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aa-pnh.org\/en\/wp-json\/wp\/v2\/tags?post=3804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}